What to Look For in Coca-Cola Earnings Tuesday Morning
Coca-Cola is scheduled to release its first-quarter earnings report before the markets open on Tuesday.
All Work
Chris Lange
What to Expect When Alphabet Reports After the Close
Alphabet is scheduled to release its most recent quarterly results after the markets close on Monday.
Can Akorn Win Its Fight Against Fresenius?
Fresenius said Sunday it would terminate its offer to acquire Akorn as the result of the latter's "failure to fulfill several closing conditions."
Why Prothena Is Crashing
Prothena shares hit a multiyear low on Monday, one that had not been seen since 2013, on the heels of news that the company would be discontinuing development of its treatment for AL amyloidosis.
Why Hasbro Is Shifting the Blame in Q1
Hasbro reported disappointing first-quarter financial results before the markets opened on Monday.
Facebook, Amazon, Alphabet and More Top Earnings to Watch For This Week
24/7 Wall St. has put together a preview of Facebook, Amazon, Ford and some of the other top companies reporting their latest results in the coming week.
Boeing, Caterpillar, Microsoft and More Dow Earnings Coming This Week
24/7 Wall St. has put together a preview of Exxon, Microsoft, Visa and the other Dow Jones industrial average companies scheduled to report their quarterly results this week.
Eli Lilly, Amgen and More Big Pharma Earnings to Look For This Week
24/7 Wall St. has put together a preview of AbbVie, Eli Lilly and some of the other top pharma and biotech companies reporting their latest quarterly results in the coming week.
Friday’s Biggest Winners and Losers in the S&P 500
Friday was a down day for the broad U.S. markets, continuing the drop from Thursday. As the first week of the earnings season comes to a close it seems the markets are marginally up.…
Why the Pivotal Software IPO Might Not Be That Great
Pivotal Software entered the market relatively quietly on Friday. There are concerns regarding Pivotal's path to profitability.
Why Excellent Earnings Weren’t Enough for Skechers
Skechers shares plunged Friday even though it reported solid quarterly results late on Thursday.
Will the FDA Shoot Down Eli Lilly and Incyte Again?
Incyte and Eli Lilly will be under the microscope next week as the FDA will decide the fate of their rheumatoid arthritis treatment.
What to Expect From the Newest Biogen Collaboration
Ionis Pharmaceuticals shares made a handy gain on Friday after the firm announced an expanded strategic collaboration with Biogen.
Should Investors Expect More From Synchrony Financial?
Synchrony Financial released its first-quarter financial results before the markets opened on Friday. Although the numbers completely beat estimates, there was only a small response from investors.
Thursday’s Biggest Winners and Losers in the S&P 500
Thursday was a down day for the broad U.S. markets, although there have been worse. Crude oil backed off slightly during the session but it is still in striking distance from $70. The S&P…
What to Expect When GE Reports Friday
General Electric is scheduled to release its most recent quarterly results before the markets open on Friday.
Why GW Pharmaceuticals Isn’t Moving, Despite a Big First for the FDA
GW Pharmaceuticals won an FDA approval for its cannabis-derived drug, but shares were relatively muted on Thursday.
Why Helios and Matheson Analytics Is Crashing
Helios Mathseson Analytics saw its shares pull back massively on Thursday after the company said it will be conducting a secondary offering to raise funds.
Procter & Gamble Earnings and Acquisition Not Enough for Investors
Procter & Gamble made a couple big announcements on Thursday that were met by investor remorse.
Aceto Has a Heart Attack
There is a lot going on for Aceto in its latest update, and most of it is not good news. Amid credit negotiations, there are also changes at the highest level of management, making…